OA-PCP Intervention for Osteoarthritis

Q: What is the essential aim of this clinical experiment?

<p>The primary purpose of this research is to assess the Change From Baseline to Month 12 for Minutes in Objectively Assessed Physical Activity. Other objectives include an examination of Change From Baseline to Month 12/6 for Steps Per Day, as well as a review of Change From Baseline to Month 6 for Moments of Sedentary Action.</p>

Q: Is the opportunity to participate in this experiment still available for patients?

<p>According to clinicaltrials.gov, this study is not presently recruiting patients; the research was published on November 30th 2020 and amended most recently on September 13th 2022. Concurrently, there are 613 other studies that are actively enrolling participants for their trials.</p>

UNC Thurston Arthritis Research Center, Chapel Hill, NC

OA-PCP Intervention +1 moreN/AWaitlist AvailableLed by Kelli D Allen, PhDResearch Sponsored by University of North Carolina, Chapel Hill

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Current Joint Symptoms

Self-reported physical activity <150 minutes per week

Must not have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Upbaseline, month 12 (follow-up)

Awards & highlights

Study Summary

This trial will test an osteoarthritis care pathway that includes physical activity screening and counseling in primary care, referral to community programs, and follow-up with patients.

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below

Select...

You are currently experiencing joint pain or discomfort.

Select...

You do less than 2.5 hours of physical activity every week.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, month 12 (follow-up)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, month 12 (follow-up)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 12 (follow-up) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change From Baseline to Month 12 for Minutes in Objectively Assessed Physical Activity (accelerometer)

Change From Baseline to Month 6 in Objectively Assessed Physical Activity (accelerometer)

Secondary outcome measures

Change From Baseline to Month 12 for Minutes of Sedentary Activity

Change From Baseline to Month 12 for Steps Per Day

Change From Baseline to Month 12 in Western Ontario and McMasters Universities Osteoarthritis (WOMAC) Function Subscale

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: OA-PCPExperimental Treatment1 Intervention

Participants assigned to the OA-PCP intervention will receive an initial physical activity (PA) coaching call then, 5 more calls over the course of 12 months. Participants, if they agree, will also receive monthly check-in emails between phone calls.

Group II: Attention ControlPlacebo Group1 Intervention

Participants assigned to the Attention Control group will receive the same number of phone calls over the course of 12 months, focused on understanding osteoarthritis (OA) and current information on treatment options. Participants, if they agree, will also receive monthly check-in emails between phone calls.

0 / 2Eligibility criteria met

Find a site

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor

1,435 Previous Clinical Trials

4,056,217 Total Patients Enrolled

23 Trials studying Osteoarthritis

1,585 Patients Enrolled for Osteoarthritis

National Institutes of Health (NIH)NIH

2,611 Previous Clinical Trials

6,804,599 Total Patients Enrolled

20 Trials studying Osteoarthritis

4,566 Patients Enrolled for Osteoarthritis

National Institute on Aging (NIA)NIH

1,554 Previous Clinical Trials

5,220,116 Total Patients Enrolled

27 Trials studying Osteoarthritis

9,662 Patients Enrolled for Osteoarthritis

Kelli D Allen, PhDPrincipal Investigator

UNC Chapel Hill

8 Previous Clinical Trials

1,530 Total Patients Enrolled

6 Trials studying Osteoarthritis

1,410 Patients Enrolled for Osteoarthritis

Media Library

OA-PCP Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04533711 — N/A

Osteoarthritis Research Study Groups: OA-PCP, Attention Control

Osteoarthritis Clinical Trial 2023: OA-PCP Intervention Highlights & Side Effects. Trial Name: NCT04533711 — N/A

OA-PCP Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04533711 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the essential aim of this clinical experiment?

"The primary purpose of this research is to assess the Change From Baseline to Month 12 for Minutes in Objectively Assessed Physical Activity. Other objectives include an examination of Change From Baseline to Month 12/6 for Steps Per Day, as well as a review of Change From Baseline to Month 6 for Moments of Sedentary Action."

Answered by AI

Is the opportunity to participate in this experiment still available for patients?

"According to clinicaltrials.gov, this study is not presently recruiting patients; the research was published on November 30th 2020 and amended most recently on September 13th 2022. Concurrently, there are 613 other studies that are actively enrolling participants for their trials."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Physical Activity Pathway for Patients With Osteoarthritis in Primary Care (OA-PCP) (R33)

2020. "Physical Activity Pathway for Patients With Osteoarthritis in Primary Care (OA-PCP) (R33)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04533711.